These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1970743)

  • 1. Synthesis, purification, and characterization of an Arg152----Glu site-directed mutant of recombinant human blood clotting factor VII.
    Wildgoose P; Berkner KL; Kisiel W
    Biochemistry; 1990 Apr; 29(13):3413-20. PubMed ID: 1970743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initiation of the extrinsic pathway of blood coagulation: evidence for the tissue factor dependent autoactivation of human coagulation factor VII.
    Nakagaki T; Foster DC; Berkner KL; Kisiel W
    Biochemistry; 1991 Nov; 30(45):10819-24. PubMed ID: 1932002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human plasma and recombinant factor VII. Characterization of O-glycosylations at serine residues 52 and 60 and effects of site-directed mutagenesis of serine 52 to alanine.
    Bjoern S; Foster DC; Thim L; Wiberg FC; Christensen M; Komiyama Y; Pedersen AH; Kisiel W
    J Biol Chem; 1991 Jun; 266(17):11051-7. PubMed ID: 1904059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepsin, a putative membrane-associated serine protease, activates human factor VII and initiates a pathway of blood coagulation on the cell surface leading to thrombin formation.
    Kazama Y; Hamamoto T; Foster DC; Kisiel W
    J Biol Chem; 1995 Jan; 270(1):66-72. PubMed ID: 7814421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a calcium binding site in the protease domain of human blood coagulation factor VII: evidence for its role in factor VII-tissue factor interaction.
    Wildgoose P; Foster D; Schiødt J; Wiberg FC; Birktoft JJ; Petersen LC
    Biochemistry; 1993 Jan; 32(1):114-9. PubMed ID: 8418832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that an Arg79-->Gln substitution in human factor VII is not associated with a reduction in coagulant activity.
    Kazama Y; Foster DC; Kisiel W
    Blood Coagul Fibrinolysis; 1992 Dec; 3(6):697-702. PubMed ID: 1489892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor VII central. A novel mutation in the catalytic domain that reduces tissue factor binding, impairs activation by factor Xa, and abolishes amidolytic and coagulant activity.
    Bharadwaj D; Iino M; Kontoyianni M; Smith KJ; Foster DC; Kisiel W
    J Biol Chem; 1996 Nov; 271(48):30685-91. PubMed ID: 8940045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional consequences of mutations in Ser-52 and Ser-60 in human blood coagulation factor VII.
    Iino M; Foster DC; Kisiel W
    Arch Biochem Biophys; 1998 Apr; 352(2):182-92. PubMed ID: 9587405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a cDNA coding for human factor VII.
    Hagen FS; Gray CL; O'Hara P; Grant FJ; Saari GC; Woodbury RG; Hart CE; Insley M; Kisiel W; Kurachi K
    Proc Natl Acad Sci U S A; 1986 Apr; 83(8):2412-6. PubMed ID: 3486420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloning and expression of rat coagulation factor VII.
    Seetharam S; Murphy K; Atkins C; Feuerstein G
    Thromb Res; 2003 Feb; 109(4):225-31. PubMed ID: 12757778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystallization and preliminary X-ray analysis of active site-inhibited human coagulation factor VIIa (des-Gla).
    Johnson DJ; Nugent PG; Tuddenham EG; Harlos K; Kemball-Cook G
    J Struct Biol; 1999 Mar; 125(1):90-3. PubMed ID: 10196120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zymogen/enzyme discrimination using peptide chloromethyl ketones.
    Williams EB; Krishnaswamy S; Mann KG
    J Biol Chem; 1989 May; 264(13):7536-45. PubMed ID: 2708377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and purification of recombinant rabbit factor VII.
    Ruiz SM; Sridhara S; Blajchman MA; Clarke BJ
    Thromb Res; 2000 Apr; 98(2):203-11. PubMed ID: 10713322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor VII Mie: homozygous asymptomatic type I deficiency caused by an amino acid substitution of His (CAC) for Arg(247) (CGC) in the catalytic domain.
    Ohiwa M; Hayashi T; Wada H; Minamikawa K; Shirakawa S; Suzuki K
    Thromb Haemost; 1994 Jun; 71(6):773-7. PubMed ID: 7974346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel gene mutation in the 60s loop of human coagulation factor VII - inhibition of interdomain crosstalk.
    Kavlie A; Wiiger MT; Husbyn M; Stormorken H; Prydz H
    Thromb Haemost; 2004 Jan; 91(1):28-37. PubMed ID: 14691565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineered recombinant factor VII Q217 variants with altered inhibitor specificities.
    Chang YJ; Hamaguchi N; Chang SC; Ruf W; Shen MC; Lin SW
    Biochemistry; 1999 Aug; 38(34):10940-8. PubMed ID: 10460149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and fast preparation of biologically active recombinant human coagulation factor VII in CHO-K1 cells.
    Xiao W; Li CQ; Xiao XP; Lin FZ
    Genet Mol Res; 2013 Dec; 12(4):6813-24. PubMed ID: 24391029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amino acid sequence and posttranslational modifications of human factor VIIa from plasma and transfected baby hamster kidney cells.
    Thim L; Bjoern S; Christensen M; Nicolaisen EM; Lund-Hansen T; Pedersen AH; Hedner U
    Biochemistry; 1988 Oct; 27(20):7785-93. PubMed ID: 3264725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monocytes can be induced by lipopolysaccharide-triggered T lymphocytes to express functional factor VII/VIIa protease activity.
    Tsao BP; Fair DS; Curtiss LK; Edgington TS
    J Exp Med; 1984 Apr; 159(4):1042-57. PubMed ID: 6368733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoaffinity purification of bovine factor VII.
    Bach R; Oberdick J; Nemerson Y
    Blood; 1984 Feb; 63(2):393-8. PubMed ID: 6362751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.